Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
63,492,417
-
Shares change
-
+6,164,933
-
Total reported value, excl. options
-
$3,058,372,144
-
Value change
-
+$301,569,077
-
Put/Call ratio
-
22.51%
-
Number of buys
-
105
-
Number of sells
-
-78
-
Price
-
$48.17
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q1 2019
223 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q1 2019.
NovoCure Ltd - Common Stock (NVCR) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63,492,417 shares
of 111,111,111 outstanding shares and own 57.14% of the company stock.
Largest 10 shareholders include FMR LLC (10,437,688 shares), BAILLIE GIFFORD & CO (8,039,525 shares), VANGUARD GROUP INC (6,315,973 shares), Capital World Investors (5,034,397 shares), BlackRock Inc. (4,804,258 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,936,247 shares), RENAISSANCE TECHNOLOGIES LLC (1,856,270 shares), Darsana Capital Partners LP (1,750,000 shares), STATE STREET CORP (1,348,637 shares), and CREDIT SUISSE AG/ (1,181,810 shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.